Invention Grant
- Patent Title: EBNA1 inhibitor crystalline forms, and methods of preparing and using same
-
Application No.: US16414198Application Date: 2019-05-16
-
Publication No.: US11242338B2Publication Date: 2022-02-08
- Inventor: Troy E. Messick , Paul M. Lieberman , Garry R. Smith , Arlindo L. Castelhano
- Applicant: THE WISTAR INSTITUTE
- Applicant Address: US PA Philadelphia
- Assignee: THE WISTAR INSTITUTE
- Current Assignee: THE WISTAR INSTITUTE
- Current Assignee Address: US PA Philadelphia
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Kathryn Doyle; Domingos Silva
- Main IPC: A61K45/06
- IPC: A61K45/06 ; A61K31/404 ; A61P31/22 ; A61P35/02 ; A61P25/28 ; C07D405/12 ; A61K9/00
Abstract:
The invention relates, in certain aspects, to developable forms of certain compounds that are useful to treat and/or prevent EBV infection and related conditions in a subject. The invention further provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection and/or lytic EBV infection.
Public/Granted literature
- US20190352285A1 EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Using Same Public/Granted day:2019-11-21
Information query
